Please provide your email address to receive an email when new articles are posted on . The myriad manifestations of herpes simplex keratitis can be difficult to diagnose without a high suspicion, but ...

Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Herpes Simplex Keratitis Treatment Market Report 2025" report has been added to ResearchAndMarkets.com's offering. The herpes simplex keratitis treatment ...

Please provide your email address to receive an email when new articles are posted on . Visual outcomes of children with herpes simplex keratitis were better when patients were seen within 5 days of ...

In a recent study published in the Virology Journal, a group of researchers evaluated the antiviral efficacy and therapeutic potential of harmol in treating herpes simplex virus type 1 (HSV-1) induced ...

Researchers from Excision Biotherapeutics Inc. and affiliated organizations have reported the development of a novel CRISPR/Cas9-mediated genome editing therapy – EBT-104 – for the treatment of latent ...

- Excision’s proprietary gene editing technology holds unique, curative potential to address the leading cause of corneal blindness in the United States - Global incidence of HSV keratitis is ...

SAN FRANCISCO, April 22, 2024 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a clinical-stage biotechnology company developing CRISPR-based therapies to cure serious ...

(MENAFN- GlobeNewsWire - Nasdaq) The herpes simplex keratitis treatment market is expanding due to rising HSV infections, increased healthcare spending, telemedicine adoption, and innovative therapies ...

- Treatment with EBT-104 led to complete elimination of viral shedding in 92% eyes of treated rabbits - Excision’s proprietary gene editing technology holds unique, curative potential to address the ...